Incoming and outgoing links Chronic prurigo
Back to articleIncoming links
- Aprepitant
- Chronic lymphocytic leukemia
- Collagenosis reactive perforating
- Cxcl2
- Diabetic pruritus
- Dupilumab
- Dystrophic epidermolysis bullosa pruriginosa recessive
- Gabapentin
- Granulocyte eosinophile
- Hodgkin's lymphoma, skin manifestations
- Hyde, james nevin
- Hypertrophic Lichen planus
- Interleukin-31
- Kyrle's disease
- Lichen amyloidosis
- Lichen corneus disseminatus
- Lichen obtusus corneus
- Lighting specifications circonscrits nodulaires chroniques
- Lymphomatoids papulose
- Maculopapulosis lichenificatio
- Monoclonal antibodies
- Naltrexone
- Nemolizumab
- Neurodermatitis nodosa
- Nodular lichenification
- Obtuse papulae
- Papular dermatitis of pregnancy
- Prurigo, nodular
- Prurigo nodularis
- Prurigo simplex subacuta
- Thalidomide
- Tofacitinib
- Urticaria perstans chronica papulosa
- Urticaria perstans verrucosa
- Vixarelimab
Outgoing links
- Abrocitinib
- Amitriptyline
- Antihistamines, systemic
- Aprepitant
- Atopic dermatitis (overview)
- Baricitinib
- Bullous Pemphigoid
- Ciclosporin a
- Clemastine
- Cryosurgery
- Cxcl2
- Dimetinden
- Dupilumab
- Dye laser
- Ecp
- Gabapentin
- Glucocorticosteroids
- Gluten
- Hydroxycin
- Hypertrophic Lichen planus
- IL31RA gene
- Imp3
- Interleukin-31
- Intraepidermal nerve fiber density
- Jak-stat signal path
- Januskinase 2
- Janus kinase inhibitors
- Keratoacanthomas multiple eruptive
- Koebner phenomenon
- Laser
- Mast cell
- Matrix metalloproteinases
- Nemolizumab
- Nerve growth factor
- Off-label use
- Oncostatin-M-Receptor
- Pregabalin
- Prostaglandins
- Prurigo simplex subacuta
- Puva therapy
- Rheumatoid arthritis and skin manifestations
- Small fiber neuropathy
- Thalidomide
- Tofacitinib
- Triamcinolone
- Tryptase
- Upadacitinib
- Vixarelimab